[ad_1] Bausch + Lomb Corp.’s decision to bring back Brent Saunders as CEO hints at…
diagnostic
-
-
STOCK MARKET
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
by userby user[ad_1] Back around 2005, in a pharmaceutical research lab in Nutley, N.J., Becky Taub noticed…
-
[ad_1] General Electric Co. is scheduled to report next week its final quarterly results before…
-
STOCK MARKET
Pfizer could sell some assets, convert others into new companies amid broader refocus
by userby user[ad_1] Drug maker Pfizer Inc. could part with or distance itself from some of its…
-
[ad_1] GE Healthcare Technologies Inc. will be an S&P 500 stock as soon as it…
-
[ad_1] General Electric Co.’s healthcare spinoff on Wednesday gave investors a peek at its balance…
-
STOCK MARKET
Elon Musk says Neuralink could help create superhuman intelligence. But the technology could be a rare failure for one of his companies
by userby user[ad_1] Elon Musk’s Neuralink has recently been in the news, and not because the private…
-
STOCK MARKET
Elon Musk’s Neuralink under federal investigation for animal-welfare violations: report
by userby user[ad_1] Elon Musk’s Neuralink Corporation is under federal investigation for possible animal welfare violations, according…
-
STOCK MARKET
Chamath Palihapitiya slams media for not uncovering FTX problems ahead of collapse
by userby user[ad_1] “The way that [Sam Bankman-Fried] was able to get away with it is that…
-
STOCK MARKET
Elon Musk claims Neuralink brain implants could be ready to test in humans in 6 months
by userby user[ad_1] Elon Musk‘s startup Neuralink Corp. should be ready to test its technology on humans…